期刊论文详细信息
Health and Quality of Life Outcomes
Health-related quality of life and survival in Chinese patients with chronic liver disease
Jian Yu Hao1  Zhan Min Shang1  Guang Li1  Ru Gao1  Feng Gao1 
[1] Digestive Department, Beijing Chao-Yang Hospital, Capital Medical University, No.8 Gong Ren Ti Yu Chang Nan Road, Chao Yang District, Beijing 100020, China
关键词: Survival;    SF-36;    Chronic liver disease;    Health-related quality of life;   
Others  :  823390
DOI  :  10.1186/1477-7525-11-131
 received in 2013-03-23, accepted in 2013-07-30,  发布年份 2013
PDF
【 摘 要 】

Background

To investigate the relationship between health-related quality of life (HRQOL) and survival in Chinese patients with chronic liver disease (CLD).

Methods

HRQOL was measured with the Chinese version of Short Form 36 (SF-36). SF-36 scores, demographic and clinical data were collected at baseline and after 18 months follow-up. Kaplan-Meier and Cox Proportional Hazard Regression survival analyses were used for interpretation of data. Surviving patients were censored in the analyses.

Results

A total of 415 Chinese patients with CLD and 86 healthy controls were enrolled. During the follow-up period 50 patients died. SF-36 scores in healthy controls and surviving patients were higher compared with those in deceased patients. Scores of physical component summary (PCS) in healthy controls, surviving and deceased patients were 54.1 ± 5.2, 48.9 ± 7.7 and 33.5 ± 8.2 respectively (p < 0.001). Scores of mental component summary (MCS) in healthy controls, surviving and deceased patients were 56.6 ± 8.2, 53.0 ± 5.6 and 37.1 ± 12.1 (p < 0.001) respectively. Survival was significantly associated with PCS and MCS scores, and the presence of ascites.

Conclusions

HRQOL was associated with survival in patients with CLD. PCS and MCS scores were predictors of survival.

【 授权许可】

   
2013 Gao et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140713003512757.pdf 534KB PDF download
Figure 4. 47KB Image download
Figure 3. 48KB Image download
Figure 2. 45KB Image download
Figure 1. 47KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Rahimi RS, Rockey DC: Complications and outcomes in chronic liver disease. Curr Opin Gastroenterol 2011, 27(3):204-209.
  • [2]Jang JW: Current status of liver diseases in Korea: liver cirrhosis. Korean J Hepatol 2009, 15(Suppl 6):S40-49.
  • [3]Testa MA, Simonson DC: Assessment of quality of life outcomes. N Engl J Med 1996, 334(1):835-840.
  • [4]Dann AA, Kallman JB, Srivastava R, Younoszai Z, Kim A, Younossi ZM: Impact of chronic liver disease and cirrhosis on health utilities using SF-6d and the health utility index. Liver Transpl 2008, 14(3):321-326.
  • [5]Glise H, Wiklund Z: Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol 2002, 17(suppl):s72-s84.
  • [6]Martin LM, Younossi ZM: Health-related quality of life (HRQL) in chronic liver disease. Dig Liver Dis 2005, 37(11):819-820.
  • [7]van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW: Generic and disease specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterol 2003, 3:33. BioMed Central Full Text
  • [8]Tanikella R, Kawut SM, Brown RS, Krowka MJ, Reinen J, Dinasarapu CR, Trotter JF, Roberts KE, Mohd MA, Arnett DK, Fallon MB: Health-related quality of life and survival in liver transplant candidates. Liver Transpl 2010, 16(2):238-245.
  • [9]Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY: Psychometrics of the chronic liver disease questionnaire for southern Chinese patients with chronic hepatitis B virus infection. World J Gastroenterol 2009, 15(26):3288-3297.
  • [10]Martin LM, Sheridan MJ, Younossi ZM: The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep 2002, 4(1):79-83.
  • [11]Rannard A, Buck D, Jones DEJ, James OF, Jacoby A: Assessing quality of life in primary biliary cirrhosis. Clinl Gastroenterol Hepatol 2004, 2(2):164-174.
  • [12]Wong GL, Law FM, Wong VW, Hui AY, Chan HC, Sung JJ, Chan HL: Health-related quality of life in Chinese patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2008, 23(4):592-598.
  • [13]Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY: Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes 2009, 7:52. BioMed Central Full Text
  • [14]Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B: Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 2006, 17(7):1083-1089.
  • [15]Diouf M, Filleron T, Barbare JC, Fin L, Picard C, Bouche O, Dahan L, Paoletti X, Bonnetain F: The added value of quality of life (QOL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. J Hepatol 2013, 58(3):509-521.
  • [16]Tanikella R, Kawut SM, Brown RS Jr, Krowka MJ, Reinen J, Dinasarapu CR, Trotter JF, Roberts KE, Mohd MA, Arnett DK, Fallon MB: Health-related qualityt of life and survival in liver transplant candidates. Liver Transpl 2010, 16(2):238-245.
  • [17]Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Han SB, Saab S, Bolus R, Spiegel BM: Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol 2009, 7(7):793-799.
  • [18]European Association For The Study Of The Liver: EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009, 50(2):227-242.
  • [19]Ghany MG, Strader DB, Thomas DL, Seeff LB: American association for the study of liver disease: diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 79(4):1335-1374.
  • [20]European Association For The Study Of The Liver: EASL clinical practice guideline: management of cholestatic liver disease. J Hepatol 2009, 51(2):237-267.
  • [21]O’Shea RS, Dadarathy S, McCullough AJ, Practice Committee of the American College of Gastroenterology: Alcoholic liver disease. Hepatology 2010, 51(1):307-328.
  • [22]Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, Dienes PR, Lohse AW, International Autoimmune Hepatitis Group: Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48(1):169-176.
  • [23]Gutteling JJ, de Man RA, van der Plas SM, Schalm SW, Busschbach JJ, Darlington AS: Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther 2006, 23(11):1629-1635.
  • [24]Younossi ZM, Guyatt G: Quality-of-life assessments and chronic liver disease. Am J Gastroenterol 1998, 93(7):1037-1041.
  • [25]Unal G, de Boer JB, Borsboom GJ, Brouwer JT, Essink-Bot M, de Man RA: A psychometric comparison of health-related quality of life measures in chronic liver disease. J Clin Epidemiol 2001, 54(6):587-596.
  • [26]van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW: The liver disease symptom index 2.0; validation of a disease-specific questionnaire. Qual Life Res 2004, 13(8):1469-1481.
  • [27]Steel JL, Chopra K, Olek MC, Carr BI: Health-related quality of life: hepatocellular carcinoma, chronic liver disease, and the general population. Qual Life Res 2007, 16(2):203-215.
  • [28]Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D: Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45(2):295-300.
  • [29]Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P: Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0. Am J Gastroenterol 2000, 95(12):3552-3265.
  • [30]Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C: Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001, 120(1):170-178.
  • [31]Gao R, Gao F, Li G, Hao JY: Health-related quality of life in Chinese patients with chronic liver disease. Gastroenterology Research and Practice 2012.
  • [32]Hsu SJ, Huang HC: Management of ascites in patients with liver cirrhosis: recent evidence and controversies. J Chin Med Assoc 2013, 76(3):123-30.
  • [33]Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA: Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 2008, 26(16):2754-2760.
  • [34]Zuluaga MC, Guallar-Castillón P, López-García E, Banegas JR, Conde-Herrera M, Olcoz-Chiva M, Rodríguez-Pascual C, Rodriguez-Artalejo F: Generic and disease-specific quality of life as a predictor of long-term mortality in heart failure. Eur J Heart Fail 2010, 12(12):1372-1378.
  • [35]Peng YS, Chiang CK, Hung KY, Chang CH, Lin CY, Yang CS, Chen TW, Hsia CC, Chen DL, Hsu WD, Chang CF, Wu KD, Lin RP, Tsai TJ, Chen WY: Are both psychological and physical dimensions in health-related quality of life associated with mortality in hemodialysis patients: a 7-year Taiwan cohort study. Blood Purif 2010, 30(2):98-105.
  • [36]Landman GW, van Hateren KJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ: Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18). Diabetes care 2010, 33(11):2378-2382.
  文献评价指标  
  下载次数:32次 浏览次数:13次